An enzyme that catalyzes the reduction of aspartic beta-semialdehyde to homoserine, which is the branch point in biosynthesis of methionine, lysine, threonine and leucine from aspartic acid. EC 1.1.1.3.
A bifunctional protein consisting of aspartokinase, and homoserine dehydrogenase activities. It is found primarily in BACTERIA and in PLANTS.
An enzyme that catalyzes the formation of beta-aspartyl phosphate from aspartic acid and ATP. Threonine serves as an allosteric regulator of this enzyme to control the biosynthetic pathway from aspartic acid to threonine. EC 2.7.2.4.
Homoserine is a non-proteinogenic amino acid, an intermediate in the biosynthesis of certain amino acids and other metabolites, with structural formula (2S)-2-amino-1-hydroxybutane-1-carboxylic acid.
An enzyme that catalyzes the conversion of L-aspartate 4-semialdehyde, orthophosphate, and NADP+ to yield L-4-aspartyl phosphate and NADPH. EC 1.2.1.11.
An essential amino acid occurring naturally in the L-form, which is the active form. It is found in eggs, milk, gelatin, and other proteins.
A subclass of enzymes which includes all dehydrogenases acting on primary and secondary alcohols as well as hemiacetals. They are further classified according to the acceptor which can be NAD+ or NADP+ (subclass 1.1.1), cytochrome (1.1.2), oxygen (1.1.3), quinone (1.1.5), or another acceptor (1.1.99).
One of the FURANS with a carbonyl thereby forming a cyclic lactone. It is an endogenous compound made from gamma-aminobutyrate and is the precursor of gamma-hydroxybutyrate. It is also used as a pharmacological agent and solvent.
A rather large group of enzymes comprising not only those transferring phosphate but also diphosphate, nucleotidyl residues, and others. These have also been subdivided according to the acceptor group. (From Enzyme Nomenclature, 1992) EC 2.7.
A species of gram-negative, facultatively anaerobic, rod-shaped bacteria found in soil, water, food, and clinical specimens. It is a prominent opportunistic pathogen for hospitalized patients.
The first enzyme in the METHIONINE biosynthetic pathway, this enzyme catalyzes the succinylation reaction of L-homoserine to O-succinyl-L-homoserine and COENZYME A using succinyl-CoA.
A genus of asporogenous bacteria that is widely distributed in nature. Its organisms appear as straight to slightly curved rods and are known to be human and animal parasites and pathogens.
Systems of enzymes which function sequentially by catalyzing consecutive reactions linked by common metabolic intermediates. They may involve simply a transfer of water molecules or hydrogen atoms and may be associated with large supramolecular structures such as MITOCHONDRIA or RIBOSOMES.
One of the non-essential amino acids commonly occurring in the L-form. It is found in animals and plants, especially in sugar cane and sugar beets. It may be a neurotransmitter.
Cyclic esters of acylated BUTYRIC ACID containing four carbons in the ring.
A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc.
A tetrameric enzyme that, along with the coenzyme NAD+, catalyzes the interconversion of LACTATE and PYRUVATE. In vertebrates, genes for three different subunits (LDH-A, LDH-B and LDH-C) exist.
A zinc-containing enzyme which oxidizes primary and secondary alcohols or hemiacetals in the presence of NAD. In alcoholic fermentation, it catalyzes the final step of reducing an aldehyde to an alcohol in the presence of NADH and hydrogen.
The rate dynamics in chemical or physical systems.
A phenomenon where microorganisms communicate and coordinate their behavior by the accumulation of signaling molecules. A reaction occurs when a substance accumulates to a sufficient concentration. This is most commonly seen in bacteria.
The functional hereditary units of BACTERIA.
Enzymes that catalyze the dehydrogenation of GLYCERALDEHYDE 3-PHOSPHATE. Several types of glyceraldehyde-3-phosphate-dehydrogenase exist including phosphorylating and non-phosphorylating varieties and ones that transfer hydrogen to NADP and ones that transfer hydrogen to NAD.
Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.
The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION.
The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells.
An enzyme that oxidizes an aldehyde in the presence of NAD+ and water to an acid and NADH. This enzyme was formerly classified as EC 1.1.1.70.
An enzyme that catalyzes the conversion of L-glutamate and water to 2-oxoglutarate and NH3 in the presence of NAD+. (From Enzyme Nomenclature, 1992) EC 1.4.1.2.
Glucose-6-Phosphate Dehydrogenase (G6PD) is an enzyme that plays a critical role in the pentose phosphate pathway, catalyzing the oxidation of glucose-6-phosphate to 6-phosphoglucono-δ-lactone while reducing nicotinamide adenine dinucleotide phosphate (NADP+) to nicotinamide adenine dinucleotide phosphate hydrogen (NADPH), thereby protecting cells from oxidative damage and maintaining redox balance.
An enzyme that catalyzes the conversion of (S)-malate and NAD+ to oxaloacetate and NADH. EC 1.1.1.37.
An enzyme of the oxidoreductase class that catalyzes the conversion of isocitrate and NAD+ to yield 2-ketoglutarate, carbon dioxide, and NADH. It occurs in cell mitochondria. The enzyme requires Mg2+, Mn2+; it is activated by ADP, citrate, and Ca2+, and inhibited by NADH, NADPH, and ATP. The reaction is the key rate-limiting step of the citric acid (tricarboxylic) cycle. (From Dorland, 27th ed) (The NADP+ enzyme is EC 1.1.1.42.) EC 1.1.1.41.
The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence.

Organization of threonine biosynthesis genes from the obligate methylotroph Methylobacillus flagellatus. (1/58)

The genes encoding aspartate kinase (ask), homoserine dehydrogenase (hom), homoserine kinase (thrB) and threonine synthase (thrC) from the obligate methylotroph Methylobacillus flagellatus were cloned. In maxicells hom and thrC directed synthesis of 51 and 48 kDa polypeptides, respectively. The hom, thrB and thrC genes and adjacent DNA areas were sequenced. Of the threonine biosynthesis genes, only hom and thrC were tightly linked in the order hom-thrC. The gene for thymidylate synthase (thyA) followed thrC and the gene for aspartate aminotransferase (aspC) preceded hom. All four genes (aspC-hom-thrC-thyA) were transcribed in the same direction. mRNA analysis indicated that hom-thrC are apparently transcribed in one 7.5 kb transcript in M. flagellatus. Promoter analysis showed the presence of a functional promoter between aspC and hom. No functional promoter was found to be associated with the DNA stretch between hom and thrC. The thrB gene encoded an unusual type of homoserine kinase and was not linked to other threonine biosynthesis genes.  (+info)

Aspartate kinase 2. A candidate gene of a quantitative trait locus influencing free amino acid content in maize endosperm. (2/58)

The maize (Zea mays) Oh545o2 inbred accumulates an exceptionally high level of free amino acids, especially lysine (Lys), threonine (Thr), methionine, and iso-leucine. In a cross between Oh545o2 and Oh51Ao2, we identified several quantitative trait loci linked with this phenotype. One of these is on the long arm of chromosome 2 and is linked with loci encoding aspartate (Asp) kinase 2 and Asp kinase (AK)-homoserine dehydrogenase (HSDH) 2. To investigate whether these enzymes can contribute to the high levels of Asp family amino acids, we measured their specific activity and feedback inhibition properties, as well as activities of several other key enzymes involved in Lys metabolism. We did not find a significant difference in total activity of dihydrodipicolinate synthase, HSDH, and Lys ketoglutarate reductase between these inbreds, and the feedback inhibition properties of HSDH and dihyrodipicolinate synthase by Lys and/or Thr were similar. The most significant difference we found between Oh545o2 and Oh51Ao2 is feedback inhibition of AK by Lys but not Thr. AK activity in Oh545o2 is less sensitive to Lys inhibition than that in Oh51Ao2, with a Lys I50 twice that of Oh51Ao2. AK activity in Oh545o2 endosperm is also higher than in Oh51Ao2 at 15 d after pollination, but not 20 d after pollination. The results indicate that the Lys-sensitive Asp kinase 2, rather than the Thr-sensitive AK-HSDH2, is the best candidate gene for the quantitative trait locus affecting free amino acid content in Oh545o2.  (+info)

Characterization of yeast homoserine dehydrogenase, an antifungal target: the invariant histidine 309 is important for enzyme integrity. (3/58)

Fungal homoserine dehydrogenase (HSD) is required for the biosynthesis of threonine, isoleucine and methionine from aspartic acid, and is a target for antifungal agents. HSD from the yeast Saccharomyces cerevisiae was overproduced in Escherichia coli and 25 mg of soluble dimeric enzyme was purified per liter of cell culture in two steps. HSD efficiently reduces aspartate semialdehyde to homoserine (Hse) using either NADH or NADPH with kcat/Km in the order of 10(6-7) M(-1) x s(-1) at pH 7.5. The rate constant of the reverse direction (Hse oxidation) was also significant at pH 9.0 (kcat/Km approximately 10(4-5) M(-1) x s(-1)) but was minimal at pH 7.5. Chemical modification of HSD with diethyl pyrocarbonate (DEPC) resulted in a loss of activity that could be obviated by the presence of substrates. UV difference spectra revealed an increase in absorbance at 240 nm for DEPC-modified HSD consistent with the modification of two histidines (His) per subunit. Amino acid sequence alignment of HSD illustrated the conservation of two His residues among HSDs. These residues, His79 and His309, were substituted to alanine (Ala) using site directed mutagenesis. HSD H79A had similar steady state kinetics to wild type, while kcat/Km for HSD H309A decreased by almost two orders of magnitude. The recent determination of the X-ray structure of HSD revealed that His309 is located at the dimer interface [B. DeLaBarre, P.R. Thompson, G.D. Wright, A.M. Berghuis, Nat. Struct. Biol. 7 (2000) 238-244]. The His309Ala mutant enzyme was found in very high molecular weight complexes rather than the expected dimer by analytical gel filtration chromatography analysis. Thus the invariant His309 plays a structural rather than catalytic role in these enzymes.  (+info)

Homoserine dehydrogenase from Saccharomyces cerevisiae: kinetic mechanism and stereochemistry of hydride transfer. (4/58)

Homoserine dehydrogenase (HSD), which is required for the synthesis of threonine, isoleucine and methionine in fungi, is a potential target for novel antifungal drugs. In order to design effective inhibitors, the kinetic mechanism of Saccharomyces cerevisiae HSD and the stereochemistry of hydride transfer were examined. Product inhibition experiments revealed that yeast HSD follows an ordered Bi Bi kinetic mechanism, where NAD(P)H must bind the enzyme prior to aspartate semialdehyde (ASA) and homoserine is released first followed by NAD(P)+. H-(1,2,4-triazol-3-yl)-D,L-alanine was an uncompetitive inhibitor of HSD with respect to NADPH (K(ii)=3.04+/-0.18 mM) and a noncompetitive inhibitor with respect to ASA (K(is)=1.64+/-0.36 mM, K(ii)=3.84+/-0.46 mM), in agreement with the proposed substrate order. Both kinetic isotope and viscosity experiments provided evidence for a very rapid catalytic step and suggest nicotinamide release to be primarily rate limiting. Incubation of HSD with stereospecifically deuterated NADP[2H] and subsaturating amounts of aspartate semialdehyde revealed that the pro-S NADPH hydride is transferred to the aldehyde. The pH dependence of steady state kinetic parameters indicate that ionizable groups with basic pKs may be involved in substrate binding, consistent with the observation of Lys223 at the enzyme active site in the recently determined 3D structure [B. DeLaBarre, P.R. Thompson, G.D. Wright, A.M. Berghuis, Nat. Struct. Biol. 7 (2000) 238-244]. These findings provide the requisite foundation for future exploitation of fungal HSD in inhibitor design.  (+info)

An integrated study of threonine-pathway enzyme kinetics in Escherichia coli. (5/58)

We have determined the kinetic parameters of the individual steps of the threonine pathway from aspartate in Escherichia coli under a single set of experimental conditions chosen to be physiologically relevant. Our aim was to summarize the kinetic behaviour of each enzyme in a single tractable equation that takes into account the effect of the products as competitive inhibitors of the substrates in the forward reaction and also, when appropriate (e.g. near-equilibrium reactions), as substrates of the reverse reactions. Co-operative feedback inhibition by threonine and lysine was also included as necessary. We derived the simplest rate equations that describe the salient features of the enzymes in the physiological range of metabolite concentrations in order to incorporate them ultimately into a complete model of the threonine pathway, able to predict quantitatively the behaviour of the pathway under natural or engineered conditions.  (+info)

Threonine synthesis from aspartate in Escherichia coli cell-free extracts: pathway dynamics. (6/58)

We have developed an experimental model of the whole threonine pathway that allows us to study the production of threonine from aspartate under different conditions. The model consisted of a desalted crude extract of Escherichia coli to which we added the substrates and necessary cofactors of the pathway: aspartate, ATP and NADPH. In this experimental model we measured not only the production of threonine, but also the time dependence of all the intermediate metabolites and of the initial substrates, aspartate, ATP and NADPH. A stoichiometric conversion of precursors into threonine was observed. We have derived conditions in which a quasi steady state can be transiently observed and used to simulate physiological conditions of functioning of the pathway in the cell. The dependence of threonine synthesis and of the aspartate and NADPH consumption on the initial aspartate and threonine concentrations exhibits greater sensitivity to the aspartate concentration than to the threonine concentration in these non-steady-state conditions. A response to threonine is only observed in a narrow concentration range from 0.23 to 2 mM.  (+info)

Control of the threonine-synthesis pathway in Escherichia coli: a theoretical and experimental approach. (7/58)

A computer simulation of the threonine-synthesis pathway in Escherichia coli Tir-8 has been developed based on our previous measurements of the kinetics of the pathway enzymes under near-physiological conditions. The model successfully simulates the main features of the time courses of threonine synthesis previously observed in a cell-free extract without alteration of the experimentally determined parameters, although improved quantitative fits can be obtained with small parameter adjustments. At the concentrations of enzymes, precursors and products present in cells, the model predicts a threonine-synthesis flux close to that required to support cell growth. Furthermore, the first two enzymes operate close to equilibrium, providing an example of a near-equilibrium feedback-inhibited enzyme. The predicted flux control coefficients of the pathway enzymes under physiological conditions show that the control of flux is shared between the first three enzymes: aspartate kinase, aspartate semialdehyde dehydrogenase and homoserine dehydrogenase, with no single activity dominating the control. The response of the model to the external metabolites shows that the sharing of control between the three enzymes holds across a wide range of conditions, but that the pathway flux is sensitive to the aspartate concentration. When the model was embedded in a larger model to simulate the variable demands for threonine at different growth rates, it showed the accumulation of free threonine that is typical of the Tir-8 strain at low growth rates. At low growth rates, the control of threonine flux remains largely with the pathway enzymes. As an example of the predictive power of the model, we studied the consequences of over-expressing different enzymes in the pathway.  (+info)

Characterization of the hom-thrC-thrB cluster in aminoethoxyvinylglycine-producing Streptomyces sp. NRRL 5331. (8/58)

Three genes from the aminoethoxyvinylglycine (AVG)-producing Streptomyces sp. NRRL 5331 involved in threonine biosynthesis, hom, thrB and thrC, encoding homoserine dehydrogenase (HDH), homoserine kinase (HK) and threonine synthase (TS), respectively, have been cloned and sequenced. The hom and thrC genes appear to be organized in a bicistronic operon as deduced by disruption experiments. The thrB gene, however, is transcribed as a monocistronic transcript. The encoded proteins are quite similar to the HDH, HK and TS proteins from other bacterial species. The overall organization of these three genes, in the order hom-thrC-thrB, differs from that in other bacteria and is similar to that reported in the Streptomyces coelicolor genome sequence. This is the first time in which the gene cluster for the three last steps of threonine biosynthesis has been characterized from a streptomycete. Disruption of thrC indicated that threonine is not a direct precursor for AVG biosynthesis in Streptomyces sp. NRRL 5331 and suggested that the branching point of the aspartic acid-derived biosynthetic route of this metabolite should lie earlier on the threonine biosynthetic route.  (+info)

Homoserine dehydrogenase is an enzyme involved in the metabolism of certain amino acids. Specifically, it catalyzes the conversion of homoserine to aspartate semialdehyde, which is a key step in the biosynthesis of several essential amino acids, including threonine, methionine, and isoleucine. The reaction catalyzed by homoserine dehydrogenase involves the oxidation of homoserine to form aspartate semialdehyde, using NAD or NADP as a cofactor. There are several isoforms of this enzyme found in different organisms, and it has been studied extensively due to its importance in amino acid metabolism and potential as a target for antibiotic development.

Aspartokinase-Homoserine Dehydrogenase is a bifunctional enzyme involved in the biosynthesis of several amino acids, specifically aspartate-family amino acids such as threonine, methionine, and lysine. This enzyme has two distinct active sites: an aspartokinase site that phosphorylates aspartate to form phosphoaspartate, and a homoserine dehydrogenase site that reduces phosphoaspartate to form homoserine.

The aspartokinase activity is responsible for the first step in the biosynthesis of aspartate-family amino acids, while the homoserine dehydrogenase activity catalyzes a later step in the pathway. The bifunctionality of this enzyme allows for the efficient regulation and coordination of the synthesis of these essential amino acids.

Defects in the gene encoding Aspartokinase-Homoserine Dehydrogenase can lead to a rare genetic disorder known as Combined Malonic and Methylmalonic Aciduria (CMAMMA), which is characterized by elevated levels of malonic and methylmalonic acids in the urine, as well as neurological symptoms such as developmental delay, seizures, and ataxia.

Aspartate kinase is a type of enzyme that plays a crucial role in the biosynthesis of several amino acids, including aspartate, methionine, and threonine. This enzyme catalyzes the phosphorylation of aspartic acid to form phosphoaspartate, which is the first step in the synthesis of these essential amino acids.

Aspartate kinase exists in different forms or isozymes in various organisms, and it can be regulated by feedback inhibition. This means that the enzyme's activity can be suppressed when the concentration of one or more of the amino acids it helps to synthesize becomes too high, preventing further production and maintaining a balanced level of these essential nutrients in the body.

In humans, aspartate kinase is involved in several metabolic pathways and is an essential enzyme for normal growth and development. Defects or mutations in the genes encoding aspartate kinase can lead to various genetic disorders and metabolic imbalances.

Homoserine is not a medical term per se, but rather a chemical compound with relevance to biochemistry and molecular biology. Homoserine is an amino acid that is not commonly encoded by DNA in the genetic code of organisms, but it can be formed through the metabolic pathways of certain amino acids. Specifically, homoserine is a non-proteinogenic amino acid that can be produced from the intermediate metabolite of methionine and threonine catabolism. It plays a crucial role in the biosynthesis of various essential compounds, such as certain amino acids and antibiotics.

While homoserine is not directly related to medical conditions or treatments, understanding its biochemical properties can contribute to broader knowledge about metabolic pathways, genetic regulation, and molecular biology, which may have implications for various areas of medicine, including pharmacology, genetics, and microbiology.

Aspartate-semialdehyde dehydrogenase (ASAD) is an enzyme that catalyzes the chemical reaction converting aspartate semialdehyde to beta-aspartyl-beta-AMP and then to beta-aspartate. This enzyme plays a crucial role in the biosynthesis of several amino acids, including lysine, threonine, and methionine. Defects in this enzyme can lead to serious genetic disorders, such as 3-methylcrotonyl-CoA carboxylase deficiency and Dwarfishism-deafness syndrome. The gene that encodes for ASAD is located on human chromosome 1 (1q21).

Threonine is an essential amino acid, meaning it cannot be synthesized by the human body and must be obtained through the diet. Its chemical formula is HO2CCH(NH2)CH(OH)CH3. Threonine plays a crucial role in various biological processes, including protein synthesis, immune function, and fat metabolism. It is particularly important for maintaining the structural integrity of proteins, as it is often found in their hydroxyl-containing regions. Foods rich in threonine include animal proteins such as meat, dairy products, and eggs, as well as plant-based sources like lentils and soybeans.

Alcohol oxidoreductases are a class of enzymes that catalyze the oxidation of alcohols to aldehydes or ketones, while reducing nicotinamide adenine dinucleotide (NAD+) to NADH. These enzymes play an important role in the metabolism of alcohols and other organic compounds in living organisms.

The most well-known example of an alcohol oxidoreductase is alcohol dehydrogenase (ADH), which is responsible for the oxidation of ethanol to acetaldehyde in the liver during the metabolism of alcoholic beverages. Other examples include aldehyde dehydrogenases (ALDH) and sorbitol dehydrogenase (SDH).

These enzymes are important targets for the development of drugs used to treat alcohol use disorder, as inhibiting their activity can help to reduce the rate of ethanol metabolism and the severity of its effects on the body.

4-Butyrolactone, also known as gamma-butyrolactone (GBL) or 1,4-butanolide, is a chemical compound with the formula C4H6O2. It is a colorless oily liquid that is used in various industrial and commercial applications, including as an intermediate in the production of other chemicals, as a solvent, and as a flavoring agent.

In the medical field, 4-butyrolactone has been studied for its potential use as a sleep aid and muscle relaxant. However, it is not currently approved by regulatory agencies such as the US Food and Drug Administration (FDA) for these uses. It is also known to have abuse potential and can cause intoxication, sedation, and other central nervous system effects when ingested or inhaled.

It's important to note that 4-butyrolactone is not a medication and should only be used under the supervision of a qualified healthcare professional for approved medical purposes.

Phosphotransferases are a group of enzymes that catalyze the transfer of a phosphate group from a donor molecule to an acceptor molecule. This reaction is essential for various cellular processes, including energy metabolism, signal transduction, and biosynthesis.

The systematic name for this group of enzymes is phosphotransferase, which is derived from the general reaction they catalyze: D-donor + A-acceptor = D-donor minus phosphate + A-phosphate. The donor molecule can be a variety of compounds, such as ATP or a phosphorylated protein, while the acceptor molecule is typically a compound that becomes phosphorylated during the reaction.

Phosphotransferases are classified into several subgroups based on the type of donor and acceptor molecules they act upon. For example, kinases are a subgroup of phosphotransferases that transfer a phosphate group from ATP to a protein or other organic compound. Phosphatases, another subgroup, remove phosphate groups from molecules by transferring them to water.

Overall, phosphotransferases play a critical role in regulating many cellular functions and are important targets for drug development in various diseases, including cancer and neurological disorders.

"Serratia marcescens" is a medically significant species of gram-negative, facultatively anaerobic, motile bacillus bacteria that belongs to the family Enterobacteriaceae. It is commonly found in soil, water, and in the gastrointestinal tracts of humans and animals. The bacteria are known for their ability to produce a red pigment called prodigiosin, which gives them a distinctive pink color on many types of laboratory media.

"Serratia marcescens" can cause various types of infections, including respiratory tract infections, urinary tract infections, wound infections, and bacteremia (bloodstream infections). It is also known to be an opportunistic pathogen, which means that it primarily causes infections in individuals with weakened immune systems, such as those with chronic illnesses or who are undergoing medical treatments that suppress the immune system.

In healthcare settings, "Serratia marcescens" can cause outbreaks of infection, particularly in patients who are hospitalized for extended periods of time. It is resistant to many commonly used antibiotics, which makes it difficult to treat and control the spread of infections caused by this organism.

In addition to its medical significance, "Serratia marcescens" has also been used as a model organism in various areas of microbiological research, including studies on bacterial motility, biofilm formation, and antibiotic resistance.

Homoserine O-succinyltransferase is an enzyme involved in the biosynthesis of the amino acids methionine and threonine in bacteria. The enzyme catalyzes the transfer of a succinyl group from succinyl-CoA to the hydroxyl group of homoserine, forming O-succinylhomoserine. This reaction is the second step in the biosynthetic pathway, following the conversion of aspartate to homoserine by homoserine transsuccinylase. The enzyme is a target for the development of antibacterial agents, as its inhibition can disrupt the bacterial production of methionine and threonine, which are essential amino acids for bacterial growth.

Corynebacterium is a genus of Gram-positive, rod-shaped bacteria that are commonly found on the skin and mucous membranes of humans and animals. Some species of Corynebacterium can cause disease in humans, including C. diphtheriae, which causes diphtheria, and C. jeikeium, which can cause various types of infections in immunocompromised individuals. Other species are part of the normal flora and are not typically pathogenic. The bacteria are characterized by their irregular, club-shaped appearance and their ability to form characteristic arrangements called palisades. They are facultative anaerobes, meaning they can grow in the presence or absence of oxygen.

Multienzyme complexes are specialized protein structures that consist of multiple enzymes closely associated or bound together, often with other cofactors and regulatory subunits. These complexes facilitate the sequential transfer of substrates along a series of enzymatic reactions, also known as a metabolic pathway. By keeping the enzymes in close proximity, multienzyme complexes enhance reaction efficiency, improve substrate specificity, and maintain proper stoichiometry between different enzymes involved in the pathway. Examples of multienzyme complexes include the pyruvate dehydrogenase complex, the citrate synthase complex, and the fatty acid synthetase complex.

Aspartic acid is an α-amino acid with the chemical formula HO2CCH(NH2)CO2H. It is one of the twenty standard amino acids, and it is a polar, negatively charged, and hydrophilic amino acid. In proteins, aspartic acid usually occurs in its ionized form, aspartate, which has a single negative charge.

Aspartic acid plays important roles in various biological processes, including metabolism, neurotransmitter synthesis, and energy production. It is also a key component of many enzymes and proteins, where it often contributes to the formation of ionic bonds and helps stabilize protein structure.

In addition to its role as a building block of proteins, aspartic acid is also used in the synthesis of other important biological molecules, such as nucleotides, which are the building blocks of DNA and RNA. It is also a component of the dipeptide aspartame, an artificial sweetener that is widely used in food and beverages.

Like other amino acids, aspartic acid is essential for human health, but it cannot be synthesized by the body and must be obtained through the diet. Foods that are rich in aspartic acid include meat, poultry, fish, dairy products, eggs, legumes, and some fruits and vegetables.

Acyl-butyrolactones are a type of chemical compound that consists of a butyrolactone ring (a five-membered ring containing an oxygen atom and a carbonyl group) that has an acyl group (a functional group consisting of a carbon atom double-bonded to an oxygen atom and single-bonded to another functional group) attached to it.

Butyrolactones are lactones, which are cyclic esters derived from carboxylic acids. The addition of an acyl group to the butyrolactone ring results in the formation of acyl-butyrolactones. These compounds have a variety of uses in organic synthesis and may also be found in some natural sources.

It's worth noting that "acyl-butyrolactones" is a general term that can refer to any compound with this basic structure, and there may be many specific compounds that fall under this category. Therefore, it's important to consult a detailed chemical reference or speak with a chemist for more information on a specific acyl-butyrolactone compound.

'Escherichia coli' (E. coli) is a type of gram-negative, facultatively anaerobic, rod-shaped bacterium that commonly inhabits the intestinal tract of humans and warm-blooded animals. It is a member of the family Enterobacteriaceae and one of the most well-studied prokaryotic model organisms in molecular biology.

While most E. coli strains are harmless and even beneficial to their hosts, some serotypes can cause various forms of gastrointestinal and extraintestinal illnesses in humans and animals. These pathogenic strains possess virulence factors that enable them to colonize and damage host tissues, leading to diseases such as diarrhea, urinary tract infections, pneumonia, and sepsis.

E. coli is a versatile organism with remarkable genetic diversity, which allows it to adapt to various environmental niches. It can be found in water, soil, food, and various man-made environments, making it an essential indicator of fecal contamination and a common cause of foodborne illnesses. The study of E. coli has contributed significantly to our understanding of fundamental biological processes, including DNA replication, gene regulation, and protein synthesis.

L-Lactate Dehydrogenase (LDH) is an enzyme found in various tissues within the body, including the heart, liver, kidneys, muscles, and brain. It plays a crucial role in the process of energy production, particularly during anaerobic conditions when oxygen levels are low.

In the presence of the coenzyme NADH, LDH catalyzes the conversion of pyruvate to lactate, generating NAD+ as a byproduct. Conversely, in the presence of NAD+, LDH can convert lactate back to pyruvate using NADH. This reversible reaction is essential for maintaining the balance between lactate and pyruvate levels within cells.

Elevated blood levels of LDH may indicate tissue damage or injury, as this enzyme can be released into the circulation following cellular breakdown. As a result, LDH is often used as a nonspecific biomarker for various medical conditions, such as myocardial infarction (heart attack), liver disease, muscle damage, and certain types of cancer. However, it's important to note that an isolated increase in LDH does not necessarily pinpoint the exact location or cause of tissue damage, and further diagnostic tests are usually required for confirmation.

Alcohol dehydrogenase (ADH) is a group of enzymes responsible for catalyzing the oxidation of alcohols to aldehydes or ketones, and reducing equivalents such as NAD+ to NADH. In humans, ADH plays a crucial role in the metabolism of ethanol, converting it into acetaldehyde, which is then further metabolized by aldehyde dehydrogenase (ALDH) into acetate. This process helps to detoxify and eliminate ethanol from the body. Additionally, ADH enzymes are also involved in the metabolism of other alcohols, such as methanol and ethylene glycol, which can be toxic if allowed to accumulate in the body.

In the context of medicine and pharmacology, "kinetics" refers to the study of how a drug moves throughout the body, including its absorption, distribution, metabolism, and excretion (often abbreviated as ADME). This field is called "pharmacokinetics."

1. Absorption: This is the process of a drug moving from its site of administration into the bloodstream. Factors such as the route of administration (e.g., oral, intravenous, etc.), formulation, and individual physiological differences can affect absorption.

2. Distribution: Once a drug is in the bloodstream, it gets distributed throughout the body to various tissues and organs. This process is influenced by factors like blood flow, protein binding, and lipid solubility of the drug.

3. Metabolism: Drugs are often chemically modified in the body, typically in the liver, through processes known as metabolism. These changes can lead to the formation of active or inactive metabolites, which may then be further distributed, excreted, or undergo additional metabolic transformations.

4. Excretion: This is the process by which drugs and their metabolites are eliminated from the body, primarily through the kidneys (urine) and the liver (bile).

Understanding the kinetics of a drug is crucial for determining its optimal dosing regimen, potential interactions with other medications or foods, and any necessary adjustments for special populations like pediatric or geriatric patients, or those with impaired renal or hepatic function.

Quorum sensing is a type of cell-cell communication that allows bacteria to detect and respond to changes in population density by producing, releasing, and responding to signaling molecules called autoinducers. This process enables the coordinated expression of certain genes related to various group behaviors such as biofilm formation, virulence factor production, and bioluminescence. The term "quorum sensing" was coined in 1994 by Bonnie L. Bassler and Susan Goldberg to describe this population-dependent gene regulation mechanism in bacteria.

A bacterial gene is a segment of DNA (or RNA in some viruses) that contains the genetic information necessary for the synthesis of a functional bacterial protein or RNA molecule. These genes are responsible for encoding various characteristics and functions of bacteria such as metabolism, reproduction, and resistance to antibiotics. They can be transmitted between bacteria through horizontal gene transfer mechanisms like conjugation, transformation, and transduction. Bacterial genes are often organized into operons, which are clusters of genes that are transcribed together as a single mRNA molecule.

It's important to note that the term "bacterial gene" is used to describe genetic elements found in bacteria, but not all genetic elements in bacteria are considered genes. For example, some DNA sequences may not encode functional products and are therefore not considered genes. Additionally, some bacterial genes may be plasmid-borne or phage-borne, rather than being located on the bacterial chromosome.

Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is an enzyme that plays a crucial role in the metabolic pathway of glycolysis. Its primary function is to convert glyceraldehyde-3-phosphate (a triose sugar phosphate) into D-glycerate 1,3-bisphosphate, while also converting nicotinamide adenine dinucleotide (NAD+) into its reduced form NADH. This reaction is essential for the production of energy in the form of adenosine triphosphate (ATP) during cellular respiration. GAPDH has also been implicated in various non-metabolic processes, including DNA replication, repair, and transcription regulation, due to its ability to interact with different proteins and nucleic acids.

Molecular sequence data refers to the specific arrangement of molecules, most commonly nucleotides in DNA or RNA, or amino acids in proteins, that make up a biological macromolecule. This data is generated through laboratory techniques such as sequencing, and provides information about the exact order of the constituent molecules. This data is crucial in various fields of biology, including genetics, evolution, and molecular biology, allowing for comparisons between different organisms, identification of genetic variations, and studies of gene function and regulation.

An amino acid sequence is the specific order of amino acids in a protein or peptide molecule, formed by the linking of the amino group (-NH2) of one amino acid to the carboxyl group (-COOH) of another amino acid through a peptide bond. The sequence is determined by the genetic code and is unique to each type of protein or peptide. It plays a crucial role in determining the three-dimensional structure and function of proteins.

Molecular cloning is a laboratory technique used to create multiple copies of a specific DNA sequence. This process involves several steps:

1. Isolation: The first step in molecular cloning is to isolate the DNA sequence of interest from the rest of the genomic DNA. This can be done using various methods such as PCR (polymerase chain reaction), restriction enzymes, or hybridization.
2. Vector construction: Once the DNA sequence of interest has been isolated, it must be inserted into a vector, which is a small circular DNA molecule that can replicate independently in a host cell. Common vectors used in molecular cloning include plasmids and phages.
3. Transformation: The constructed vector is then introduced into a host cell, usually a bacterial or yeast cell, through a process called transformation. This can be done using various methods such as electroporation or chemical transformation.
4. Selection: After transformation, the host cells are grown in selective media that allow only those cells containing the vector to grow. This ensures that the DNA sequence of interest has been successfully cloned into the vector.
5. Amplification: Once the host cells have been selected, they can be grown in large quantities to amplify the number of copies of the cloned DNA sequence.

Molecular cloning is a powerful tool in molecular biology and has numerous applications, including the production of recombinant proteins, gene therapy, functional analysis of genes, and genetic engineering.

Aldehyde dehydrogenase (ALDH) is a class of enzymes that play a crucial role in the metabolism of alcohol and other aldehydes in the body. These enzymes catalyze the oxidation of aldehydes to carboxylic acids, using nicotinamide adenine dinucleotide (NAD+) as a cofactor.

There are several isoforms of ALDH found in different tissues throughout the body, with varying substrate specificities and kinetic properties. The most well-known function of ALDH is its role in alcohol metabolism, where it converts the toxic aldehyde intermediate acetaldehyde to acetate, which can then be further metabolized or excreted.

Deficiencies in ALDH activity have been linked to a number of clinical conditions, including alcohol flush reaction, alcohol-induced liver disease, and certain types of cancer. Additionally, increased ALDH activity has been associated with chemotherapy resistance in some cancer cells.

Glutamate Dehydrogenase (GLDH or GDH) is a mitochondrial enzyme that plays a crucial role in the metabolism of amino acids, particularly within liver and kidney tissues. It catalyzes the reversible oxidative deamination of glutamate to alpha-ketoglutarate, which links amino acid metabolism with the citric acid cycle and energy production. This enzyme is significant in clinical settings as its levels in blood serum can be used as a diagnostic marker for diseases that damage liver or kidney cells, since these cells release GLDH into the bloodstream upon damage.

Glyceraldehyde-3-phosphate dehydrogenase (GAPDH), also known as Glucosephosphate Dehydrogenase, is an enzyme that plays a crucial role in cellular metabolism, particularly in the glycolytic pathway. It catalyzes the conversion of glyceraldehyde 3-phosphate (G3P) to 1,3-bisphosphoglycerate (1,3-BPG), while also converting nicotinamide adenine dinucleotide (NAD+) to its reduced form NADH. This reaction is essential for the production of energy in the form of adenosine triphosphate (ATP) during cellular respiration. GAPDH has been widely used as a housekeeping gene in molecular biology research due to its consistent expression across various tissues and cells, although recent studies have shown that its expression can vary under certain conditions.

Malate Dehydrogenase (MDH) is an enzyme that plays a crucial role in the Krebs cycle, also known as the citric acid cycle or tricarboxylic acid (TCA) cycle. It catalyzes the reversible oxidation of malate to oxaloacetate, while simultaneously reducing NAD+ to NADH. This reaction is essential for energy production in the form of ATP and NADH within the cell.

There are two main types of Malate Dehydrogenase:

1. NAD-dependent Malate Dehydrogenase (MDH1): Found primarily in the cytoplasm, this isoform plays a role in the malate-aspartate shuttle, which helps transfer reducing equivalents between the cytoplasm and mitochondria.
2. FAD-dependent Malate Dehydrogenase (MDH2): Located within the mitochondrial matrix, this isoform is involved in the Krebs cycle for energy production.

Abnormal levels of Malate Dehydrogenase enzyme can be indicative of certain medical conditions or diseases, such as myocardial infarction (heart attack), muscle damage, or various types of cancer. Therefore, MDH enzyme activity is often assessed in diagnostic tests to help identify and monitor these health issues.

Isocitrate Dehydrogenase (IDH) is an enzyme that catalyzes the oxidative decarboxylation of isocitrate to α-ketoglutarate in the presence of NAD+ or NADP+, producing NADH or NADPH respectively. This reaction occurs in the citric acid cycle, also known as the Krebs cycle or tricarboxylic acid (TCA) cycle, which is a crucial metabolic pathway in the cell's energy production and biosynthesis of various molecules. There are three isoforms of IDH found in humans: IDH1 located in the cytosol, IDH2 in the mitochondrial matrix, and IDH3 within the mitochondria. Mutations in IDH1 and IDH2 have been associated with several types of cancer, such as gliomas and acute myeloid leukemia (AML), leading to abnormal accumulation of 2-hydroxyglutarate, which can contribute to tumorigenesis.

A base sequence in the context of molecular biology refers to the specific order of nucleotides in a DNA or RNA molecule. In DNA, these nucleotides are adenine (A), guanine (G), cytosine (C), and thymine (T). In RNA, uracil (U) takes the place of thymine. The base sequence contains genetic information that is transcribed into RNA and ultimately translated into proteins. It is the exact order of these bases that determines the genetic code and thus the function of the DNA or RNA molecule.

... the precise mechanism of complete homoserine dehydrogenase catalysis remains unknown. The homoserine dehydrogenase-catalyzed ... In enzymology, a homoserine dehydrogenase (EC 1.1.1.3) is an enzyme that catalyzes the chemical reaction L-homoserine + NAD(P ... Homoserine dehydrogenase catalyzes the reaction of aspartate-semialdehyde (ASA) to homoserine. The overall reaction reduces the ... Homoserine dehydrogenase has an NAD(P)H cofactor, which then donates a hydrogen to the same carbon, effectively reducing the ...
Localization and characterization of homoserine dehydrogenase isolated from barley and pea leaves. Planta. 152 (6), pp. 491-496 ... Localization and characterization of homoserine dehydrogenase isolated from barley and pea leaves. A - Papers appearing in ... repository.rothamsted.ac.uk/item/8vw33/localization-and-characterization-of-homoserine-dehydrogenase-isolated-from-barley-and- ... Alcohol-dehydrogenase in hordeum-vulgare - changes in isoenzyme levels under hypoxia. Plant science letters. 37 (1-2), pp. 73- ...
homoserine dehydrogenase [Leifsonia xyli subsp. xyli str. CTCB07]. gb,AAT88620.1, homoserine dehydrogenase [Leifsonia xyli ... GENE ID: 2939000 thrA , homoserine dehydrogenase. [Leifsonia xyli subsp. xyli str. CTCB07] (10 or fewer PubMed links). Score = ...
1.3.3. Homoserine dehydrogenase in S. cerevisiae and C. albicans 7. 1.4. Stress responses in C. albicans 8. 1.4.1. Antioxidant ... Assay for homoserine dehydrogenase activity 19. 2.11. Amino acid analysis 20. 2.12. Polysome profile 21. 2.13. Cell wall ... In this study, we found that C. albicans Hom6p has a homoserine dehydrogenase activity and is probably involved in the pathway ... 3.1.1. C. albicans Hom6p is a homoserine dehydrogenase and involves in biosynthesis of threonine and methionine. 28. 3.1.2. C. ...
Homoserine Dehydrogenase (MeSH) * Kinetics (MeSH) * Oligopeptides (MeSH) * Organic Chemistry (Science Metrix) * ...
... an aspartokinase/homoserine dehydrogenase, a glucose kinase, and a DNA mismatch repair enzyme, respectively (8). PCR products ... Bacterial cytotoxicity was evaluated by lactate dehydrogenase measurement with Cyto-Tox 96 Cytoxicity Kit (Promega, Madison, WI ...
... and histidinol dehydrogenase for histidine synthesis, homoserine kinase and threonine aldolase for serine and threonine ...
Homoserine dehydrogenase. Tree 12 [16]. 82. Histidinol-phosphate aminotransferase. Tree 12 [16] ...
The Bacillus subtilis hom gene, encoding homoserine dehydrogenase (L-homoserine:NADP+ oxidoreductase, EC 1.1.1.3) has been ... The Bacillus subtilis hom gene, encoding homoserine dehydrogenase (L-homoserine:NADP+ oxidoreductase, EC 1.1.1.3) has been ... subtilis homoserine dehydrogenase shows extensive similarity with the C-terminal part of E. coli aspartokinases-homoserine ... The B. subtilis homoserine dehydrogenase has a C-terminal extension of about 100 residues (relative to the E. coli enzymes) ...
Localization and characterization of homoserine dehydrogenase isolated from barley and pea leaves. Planta. 152 (6), pp. 491-496 ... Localization and characterization of homoserine dehydrogenase isolated from barley and pea leaves. A - Papers appearing in ... Alcohol-dehydrogenase in hordeum-vulgare - changes in isoenzyme levels under hypoxia. Plant science letters. 37 (1-2), pp. 73- ... Alcohol-dehydrogenase in hordeum-vulgare - changes in isoenzyme levels under hypoxia. A - Papers appearing in refereed journals ...
homoserine dehydrogenase 27, 40. Gene Page Help. Network Tab. If the gene is associated with a module(s), its connection to ...
aspartate semi-aldehyde dehydrogenase. SMc04410. hom. homoserine dehydrogenase. SMc00293. thrB. homoserine kinase. SMc00017. ...
homoserine dehydrogenase YP_001230938 unclonable 0.00000000677281 n/a Geobacter uraniireducens Rf4 Bacteria -. ... NAD(P)H dehydrogenase (quinone) YP_001228885 unclonable 0.000000000110916 n/a Geobacter uraniireducens Rf4 Bacteria -. ... aldehyde dehydrogenase YP_001230347 unclonable 0.00000000814705 n/a Geobacter uraniireducens Rf4 Bacteria -. ...
X-ray crystal structure of Homoserine dehydrogenase from Thermoplasma volcanium rcsb molecule keywords Homoserine dehydrogenase ... Homoserine_dh. Homoserine dehydrogenase. A. PF03447 NAD_binding_3. Homoserine dehydrogenase, NAD binding domain. ...
homoserine dehydrogenase YP_002551501 normal 0.728091 n/a Acidovorax ebreus TPSY Bacteria -. ... acyl-CoA dehydrogenase domain protein YP_002551566 normal 1 n/a Acidovorax ebreus TPSY Bacteria -. ... acyl-CoA dehydrogenase domain protein YP_002551567 normal 1 n/a Acidovorax ebreus TPSY Bacteria -. ... acyl-CoA dehydrogenase domain protein YP_002551587 normal 1 n/a Acidovorax ebreus TPSY Bacteria -. ...
Homoserine dehydrogenase, NAD binding domain. 2.7E-18. 13. 147. PF00742. Homoserine_dh. Homoserine dehydrogenase. 1.5E-52. 155 ...
S9), homoserine O-succinyltransferase ([EC:2.3.1.46], K00651) and homoserine dehydrogenase ([EC:1.1.1.3], K00003) were ... S7), sulfonate transport system substrate-binding protein (SsuACB, K15554) and homoserine O-succinyltransferase [EC:2.3.1.46] ( ...
homoserine dehydrogenase (NCBI). 52, 263. GSU1812. argS. arginyl-tRNA synthetase (NCBI). 52, 332. ...
Chain: A: homoserine dehydrogenase; c7adjA_. 2.80 membrane protein Chain: A: putative immunoglobulin-blocking virulence protein ... Chain: B: 6-phosphogluconate dehydrogenase, decarboxylating; c6xlaG_. 3.10 transcription Chain: G: merr family transcriptional ...
PREDICTED: homoserine dehydrogenase [Jatropha curcas]. 12. Hb_000060_090. 0.0700882964. transcription factor. TF Family: HSF. ...
Funciton: Homoserine dehydrogenase (EC 1.1.1.3) Locus tag: OA2633_08274. Name: metX2. Funciton: Homoserine O-acetyltransferase ...
NADP_Rossmann (CL0063) NAD_binding_3; Homoserine dehydrogenase, NAD binding domain (PF03447; HMM-score: 19.1) ... Semialdhyde_dh; Semialdehyde dehydrogenase, NAD binding domain (PF01118; HMM-score: 16.3) GT-B (CL0113) Glyco_trans_4_2; ... Metabolism Energy metabolism Sugars inositol 2-dehydrogenase (TIGR04380; EC 1.1.1.18; HMM-score: 117.7) ...
SCO0420 putative homoserine dehydrogenase 437253:438287 reverse MW:35496 0581. SCO5134 hypothetical protein 5581727:5582761 ... SCO4971 putative dehydrogenase 5406194:5407687 forward MW:52554 0286. SCO7297 putative two-component sensor histidine kinase. ... SCO0338 putative dehydrogenase 341370:341909 reverse MW:19706 1193. SCO0738 putative secreted protein 780863:781402 forward MW: ... SCO0339 putative dehydrogenase 341992:342561 forward MW:20519 1129. SCO1714 putative secreted protein 1835004:1835573 reverse ...
gi,16763392,ref,NP_459007.1, bifunctional aspartokinase I/homoserine dehydrogenase I (STM0002) [Salmonella enterica subsp. ... gi,16763393,ref,NP_459008.1, homoserine kinase (STM0003) [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2]. ...
Align fused aspartate kinase/homoserine dehydrogenase 1 (EC 2.7.2.4; EC 1.1.1.3) (characterized) to candidate 7023422 Shewana3_ ...
Mapping of the structural genes of the three aspartokinases and of the two homoserine dehydrogenases of Escherichia coli K-12. ...
Rational Design of Allosteric Regulation of Homoserine Dehydrogenase by a Non-Natural Inhibitor L-Lysine. ACS Synth. Biol.2013 ...
... aspartokinase I and homoserine dehydrogenase I. This gene was cloned in a bacterial plasmid and its complete nucleotide ... that initiation of translation may occur inside the gene to give a protein fragment having only the homoserine dehydrogenase ...

No FAQ available that match "homoserine dehydrogenase"

No images available that match "homoserine dehydrogenase"